Eris signs definitive pact to buy Strides ’ India portfolio for Rs 500 cr

The acquisition is Eris ’s fourth and the largest buyout in the last 18 months. With this, the company will be among the top ten companies in the Central Nervous System (CNS) segment.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news